Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.
more
Refresh
No publications yet
Add Northwest Biotherapeutics to your Watchlist to get alerts on new publications